As part of its international development, BIOSYNEX announces that it has acquired a 75% majority stake,
alongside the two founders, in MEDKONCEPT AS, a company based in Hellerup, near Copenhagen,
Denmark.
Founded in 2017 by Preben Joffe and Michael Lexner, MEDKONCEPT has been the exclusive distributor in
Denmark of Covid-19 related rapid diagnostic tests. MEDKONCEPT, which will soon become BIOSYNEX
NORDIC, has in fact distributed more than 26 million antigen tests on behalf of BIOSYNEX in the Danish
market since 2021.